Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis.
Lancet Gastroenterol Hepatol
; 6(12): 1002-1014, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34688373
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Placebos
/
Biological Therapy
/
Crohn Disease
/
Drug Therapy, Combination
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Language:
En
Journal:
Lancet Gastroenterol Hepatol
Year:
2021
Document type:
Article
Country of publication: